Yes, regulatory compliance documentation is mandatory if you're selling in the US, EU, UK, Canada, Australia, or most other developed markets. The scope and cost depend on where you're selling and whether you make health claims ("balances microbiome", "reduces acne-causing bacteria") or stick to cosmetic claims ("cleanses", "moisturizes"). A common mistake is assuming that because your manufacturer is "compliance-ready" or "FDA-registered", your product is automatically compliant—compliance is your legal responsibility as the brand owner, and you must verify and maintain documentation even if a co-packer handles production.
In the United States, body wash is regulated as a cosmetic under the Federal Food, Drug & Cosmetic Act unless it makes a therapeutic claim (treating acne, reducing oiliness, treating dermatitis). If you claim "balances skin microbiome" or "supports healthy bacteria", the FDA may classify it as a drug because "balancing" or "supporting" the microbiome implies a physiological effect. Staying in cosmetic territory requires careful claim language: "contains prebiotics" or "formulated with postbiotics" (descriptive, cosmetic-friendly) vs. "restores the skin microbiome" or "treats dysbiosis" (therapeutic, drug-territory claims). Under the Modernized Cosmetics Regulation (MoCRA, effective November 2023), you must register your facility (if you manufacture) or identify your contract manufacturer, list all ingredients, and assign a responsible person to oversee compliance. Your co-packer can serve as the facility; they'll provide production records, batch records, and ingredient documentation. You or your appointed formulator (often the co-packer's chemist) must prepare a Safety & Stability Summary or full safety dossier substantiating your formula. For a simple microbiome formula without novel actives, this is typically a 20–50 page document citing published safety data on each ingredient; for a custom postbiotic strain or rare prebiotic, you may need an independent stability report ($500–2,000) and preservative efficacy testing ($800–3,000). Filing cost with FDA is free; preparation and dossier creation typically runs $1,000–5,000 if you hire a regulatory consultant.
In the EU, body wash is a cosmetic under the EU Cosmetics Regulation (EC 1223/2009). Microbiome claims are allowed if they're substantiated by in vivo or in vitro studies—"clinically proven to balance skin microbiome" requires a published or proprietary study showing the product shifts bacterial populations or markers. If you avoid specific microbiome claims and stick to "contains prebiotic ingredients" or "formulated with postbiotics", regulatory burden is lower. You must compile a full Safety & Stability Dossier (Part A: ingredient information; Part B: test data on preservative efficacy, microbiological limits, stability; Part C: toxicological assessment; Part D: product information file). A third-party lab in Europe must test for microbiological limits (NCTC limits for body wash, typically <10 CFU/mL for Pseudomonas aeruginosa, <100 CFU/mL for total aerobic count). Outsourcing this dossier to a EU regulatory consultant costs €2,000–8,000 depending on formula novelty. There is no pre-market approval, but you must keep documentation on file and provide it to authorities if requested.
In the UK (post-Brexit), body wash is regulated under the UK Cosmetics Regulations (largely mirroring the EU rules). Compliance is similar to the EU but with additional UK-specific documentation; expect an extra €500–1,500 in consultant fees if working with both markets.
In Canada, body wash is regulated as a cosmetic under the Cosmetic Regulations (Health Canada). Microbiome or probiotic claims are scrutinized; Canada restricts claims about modifying the microbiome unless they're general descriptors ("contains probiotics"). Health Canada requires a Product Information File (PIF) detailing ingredient safety, stability, preservative efficacy, and microbiological limits. The process is simpler than the EU but still requires a third-party lab report for microbiological testing. Canadian regulatory cost is typically CAD $1,500–4,000.
In Australia, body wash is governed by the Australian Consumer Law and the Therapeutic Goods Administration (TGA). If you claim "balances microbiome" or "treats skin conditions", the TGA may classify it as a therapeutic good, triggering more rigorous testing and approval. Staying cosmetic requires avoiding therapeutic language. Microbiological testing by a certified Australian lab is expected; cost is AUD $1,500–3,500.
Common documentation your co-packer should provide: (1) ingredient list with INCI names and concentration ranges; (2) batch records and production records for each batch; (3) third-party stability report (or in-house data if you trust their lab), typically covering 40°C/75% RH for 8–12 weeks with checkpoints for pH, viscosity, appearance, and microbial count; (4) preservative efficacy testing (USP <51> or equivalent) confirming the formula resists microbial contamination; (5) microbial testing report (aerobic plate count, pathogen screening: E. coli, Staphylococcus aureus, Pseudomonas aeruginosa, mold/yeast); (6) raw material certificates of analysis (COAs) from ingredient suppliers. If your co-packer doesn't provide these, you must commission them from a third-party lab—expect $3,000–8,000 total.
Regulatory claims language matters. Safe claims: "contains inulin (a prebiotic)", "formulated with Vitreoscilla ferment lysate", "supports skin hydration and comfort." Risky claims: "restores the skin's natural microbiome", "prevents acne-causing bacteria", "treats dysbiosis", "balances your microbiome like probiotics do." If you're uncertain, have a regulatory consultant review your label and marketing copy ($300–800) before launch.
When sourcing on AJ Cosmo Labs, ask your potential co-packer which markets they service and what compliance documentation they include in their quote. Some manufacturers provide basic documentation (ingredient list, batch records); others include full dossier support. Budget 4–8 weeks and $2,000–8,000 for compliance preparation beyond manufacturing. If you're launching in multiple regions, prioritize the US (MoCRA) and EU (CPNP database) first because they're the largest markets and most strictly enforced.
Ingredients in this answer: Inulin
Read the full guide on Private Label Microbiome Body Wash Manufacturer: Low MOQ →